Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer

被引：2
|
作者：
Arbour, Kathryn C. [1 ]
Riely, Gregory J. [1 ]
机构：
[1] Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
来源：
CANCER | 2018年 / 124卷 / 11期
关键词：
ACQUIRED-RESISTANCE; INITIAL TREATMENT; OSIMERTINIB; MUTATIONS; ERLOTINIB; BEVACIZUMAB; INHIBITION; GEFITINIB; EMERGENCE; AZD9291;
D O I：
10.1002/cncr.31289
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2272 / 2275
页数：4
相关论文
共 50 条
  • [1] Adjuvant Targeted Therapy for Patients With Epidermal Growth Factor Receptor-Mutant Lung Cancer
    Pennell, Nathan A.
    JAMA ONCOLOGY, 2021, 7 (05) : 679 - 680
  • [2] Highly Active Antitumor Therapy (HAATT) for Epidermal Growth Factor Receptor-Mutant Lung Cancer
    Chmielecki, Juliann
    Pao, William
    CLINICAL CANCER RESEARCH, 2010, 16 (22) : 5371 - 5373
  • [3] Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor-Mutant Lung Cancer
    Fintelmann, Florian J.
    Troschel, Fabian M.
    Kuklinski, Martin W.
    McDermott, Shaunagh
    Petranovic, Milena
    Digumarthy, Subba R.
    Sharma, Amita
    Troschel, Amelie S.
    Price, Melissa C.
    Hariri, Lida P.
    Gilman, Matthew D.
    Shepard, Joanne O.
    Sequist, Lecia V.
    Piotrowska, Zofia
    ONCOLOGIST, 2019, 24 (12): : 1570 - 1576
  • [4] Prevalence of underlying lung disease in smokers with epidermal growth factor receptor-mutant lung cancer
    Sekine, Akimasa
    Tamura, Katsumi
    Satoh, Hiroaki
    Tanaka, Tomoaki
    Tsunoda, Yoshiya
    Tanaka, Toru
    Takoi, Hiroyuki
    Lin, Shih-Yuan
    Yatagai, Yohei
    Hashizume, Toshinori
    Hayasihara, Kenji
    Saito, Takefumi
    ONCOLOGY REPORTS, 2013, 29 (05) : 2005 - 2010
  • [5] Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas
    Cortot, Alexis B.
    Jaenne, Pasi A.
    EUROPEAN RESPIRATORY REVIEW, 2014, 23 (133): : 356 - 366
  • [6] Image-guided thermal ablation for patients with epidermal growth factor receptor-mutant nonsmall cell lung cancer
    Huang, Yahan
    Kong, Yongmei
    Wei, Zhigang
    Ye, Xin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (04) : 427 - 433
  • [7] Epidermal growth factor receptor-mutant lung cancer in Down syndrome: a case presentation and review of the literature
    Li, Xin
    Xing, Shijiang
    Dong, Qiumei
    ONCOTARGET, 2017, 8 (33) : 55760 - 55765
  • [8] The features and prognostic impact of extracranial metastases in patients with epidermal growth factor receptor-mutant lung adenocarcinoma
    Bi, Jianping
    Han, Guang
    Wei, Xueyan
    Pi, Guoliang
    Zhang, Yong
    Li, Ying
    Wang, Mingwei
    Hu, Desheng
    Zhen, Weining
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (04) : 799 - 806
  • [9] Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer
    Tode, Naoki
    Kikuchi, Toshiaki
    Sakakibara, Tomohiro
    Hirano, Taizou
    Inoue, Akira
    Ohkouchi, Shinya
    Tamada, Tsutomu
    Okazaki, Tatsuma
    Koarai, Akira
    Sugiura, Hisatoshi
    Niihori, Tetsuya
    Aoki, Yoko
    Nakayama, Keiko
    Matsumoto, Kunio
    Matsubara, Yoichi
    Yamamoto, Masayuki
    Watanabe, Akira
    Nukiwa, Toshihiro
    Ichinose, Masakazu
    CANCER SCIENCE, 2017, 108 (06): : 1263 - 1270
  • [10] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Metastatic to the Brain
    Jamal-Hanjani, Mariam
    Spicer, James
    CLINICAL CANCER RESEARCH, 2012, 18 (04) : 938 - 944
12345